prices for glp-1 drugs Antagonists Increase Plan Drug Spend - What's Next Putting Medical Costs on a
Description
When prescriptions were filled, the average out-of-pocket cost for a 30-day supply was $71.90
The ASA revised its practice guideline in December 2024, issuing a multi-society guideline
Dipeptidyl Peptidase-4 (DPP-4) Inhibitors In the Management of Diabetes
doi: 10.1080/20018525.2025.2484048, 49
A: It is the first triple agonist (GLP-1 + GIP + Glucagon) studied in Phase 3 trials
doi: 10.1186/s12902-024-01798-9
